SIGA Technologies, Inc. (SIGA)
USD 6.12
(2.43%)
USD 6.12
(2.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 84.15 Million USD | 92.44% |
| 2022 | 43.21 Million USD | -51.26% |
| 2021 | 89.61 Million USD | 4.85% |
| 2020 | 85.03 Million USD | 8230.61% |
| 2019 | 1.02 Million USD | -99.76% |
| 2018 | 355.16 Million USD | 2584.21% |
| 2017 | -23.43 Million USD | 16.12% |
| 2016 | -25.44 Million USD | -28.16% |
| 2015 | -38.47 Million USD | 22.03% |
| 2014 | -211.12 Million USD | 7.5% |
| 2013 | -23.12 Million USD | -1.91% |
| 2012 | -21.77 Million USD | 44.37% |
| 2011 | -21.86 Million USD | -1277.67% |
| 2010 | -27.56 Million USD | 159.59% |
| 2009 | -11.4 Million USD | 32.68% |
| 2008 | -8.27 Million USD | -4.68% |
| 2007 | -6.21 Million USD | -271.04% |
| 2006 | -5.25 Million USD | -49.44% |
| 2005 | -1.2 Million USD | 72.2% |
| 2004 | -8.31 Million USD | -18.0% |
| 2003 | -4.55 Million USD | -44.96% |
| 2002 | -3.04 Million USD | -31.8% |
| 2001 | -2.7 Million USD | 61.34% |
| 2000 | -6.13 Million USD | -92.99% |
| 1999 | -3.08 Million USD | 16.22% |
| 1998 | -5 Million USD | -68.18% |
| 1997 | -1.8 Million USD | -340.0% |
| 1996 | -500 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 11.41 Million USD | -87.57% |
| 2024 Q2 | 1.22 Million USD | -89.31% |
| 2023 Q2 | -4.63 Million USD | -134.59% |
| 2023 Q3 | -1.17 Million USD | 74.7% |
| 2023 Q4 | 91.81 Million USD | 7925.2% |
| 2023 Q1 | -1.97 Million USD | -720.66% |
| 2023 FY | - USD | 92.44% |
| 2022 Q4 | -240.92 Thousand USD | -100.56% |
| 2022 FY | - USD | -51.26% |
| 2022 Q1 | -1.66 Million USD | -101.77% |
| 2022 Q2 | 3.14 Million USD | 289.47% |
| 2022 Q3 | 43 Million USD | 1265.24% |
| 2021 Q3 | -2.78 Million USD | -1850.17% |
| 2021 Q1 | -1.83 Million USD | -106.79% |
| 2021 Q2 | 159.34 Thousand USD | 108.69% |
| 2021 Q4 | 94.17 Million USD | 3477.03% |
| 2021 FY | - USD | 4.85% |
| 2020 Q1 | -3.45 Million USD | -25.58% |
| 2020 FY | - USD | 8230.61% |
| 2020 Q3 | 33.05 Million USD | 14.12% |
| 2020 Q2 | 28.96 Million USD | 938.91% |
| 2020 Q4 | 26.99 Million USD | -18.32% |
| 2019 Q4 | -2.74 Million USD | -277.29% |
| 2019 Q2 | -840.1 Thousand USD | -127.4% |
| 2019 Q1 | 3.06 Million USD | -95.82% |
| 2019 FY | - USD | -99.76% |
| 2019 Q3 | 1.55 Million USD | 284.58% |
| 2018 Q2 | -3.56 Million USD | 20.91% |
| 2018 FY | - USD | 2584.21% |
| 2018 Q1 | -4.5 Million USD | 6.94% |
| 2018 Q3 | 368.9 Million USD | 10458.42% |
| 2018 Q4 | 73.26 Million USD | -80.14% |
| 2017 FY | - USD | 16.12% |
| 2017 Q4 | -4.83 Million USD | -10.12% |
| 2017 Q3 | -4.39 Million USD | -9.55% |
| 2017 Q2 | -4.01 Million USD | 5.15% |
| 2017 Q1 | -4.22 Million USD | 42.66% |
| 2016 Q1 | -4.08 Million USD | -15.97% |
| 2016 FY | - USD | -28.16% |
| 2016 Q3 | -4.42 Million USD | 10.18% |
| 2016 Q2 | -4.92 Million USD | -20.48% |
| 2016 Q4 | -7.37 Million USD | -66.76% |
| 2015 FY | - USD | 22.03% |
| 2015 Q3 | -3.55 Million USD | 16.54% |
| 2015 Q1 | -4.95 Million USD | -8.41% |
| 2015 Q2 | -4.25 Million USD | 14.16% |
| 2015 Q4 | -3.52 Million USD | 0.74% |
| 2014 Q2 | -4.65 Million USD | 16.07% |
| 2014 Q1 | -5.54 Million USD | 5.28% |
| 2014 Q3 | -6.17 Million USD | -32.64% |
| 2014 Q4 | -4.57 Million USD | 25.98% |
| 2014 FY | - USD | 7.5% |
| 2013 Q1 | -5.7 Million USD | -8.26% |
| 2013 FY | - USD | -1.91% |
| 2013 Q2 | -5.52 Million USD | 3.18% |
| 2013 Q3 | -5.44 Million USD | 1.44% |
| 2013 Q4 | -5.85 Million USD | -7.52% |
| 2012 Q3 | -5.28 Million USD | 15.17% |
| 2012 Q1 | -5 Million USD | 37.92% |
| 2012 FY | - USD | 44.37% |
| 2012 Q4 | -5.27 Million USD | 0.17% |
| 2012 Q2 | -6.22 Million USD | -24.32% |
| 2011 Q4 | -8.06 Million USD | 24.25% |
| 2011 FY | - USD | -1277.67% |
| 2011 Q3 | -10.65 Million USD | 17.86% |
| 2011 Q2 | -12.96 Million USD | -60.96% |
| 2011 Q1 | -8.05 Million USD | -253.6% |
| 2010 Q2 | -1.3 Million USD | 15.71% |
| 2010 Q1 | -1.54 Million USD | 81.59% |
| 2010 FY | - USD | 159.59% |
| 2010 Q4 | 5.24 Million USD | 2374.6% |
| 2010 Q3 | -230.59 Thousand USD | 82.28% |
| 2009 Q2 | 5.29 Million USD | 374.05% |
| 2009 FY | - USD | 32.68% |
| 2009 Q4 | -8.38 Million USD | -127.35% |
| 2009 Q3 | -3.68 Million USD | -169.69% |
| 2009 Q1 | 1.11 Million USD | 132.77% |
| 2008 FY | - USD | -4.68% |
| 2008 Q4 | -3.4 Million USD | -202.82% |
| 2008 Q3 | -1.12 Million USD | -13.21% |
| 2008 Q2 | -993.67 Thousand USD | 64.47% |
| 2008 Q1 | -2.79 Million USD | 14.84% |
| 2007 Q3 | -349.28 Thousand USD | 91.75% |
| 2007 Q2 | -4.23 Million USD | -2337.71% |
| 2007 Q1 | -173.58 Thousand USD | -128.05% |
| 2007 FY | - USD | -271.04% |
| 2007 Q4 | -3.28 Million USD | -840.34% |
| 2006 Q4 | 618.74 Thousand USD | 175.83% |
| 2006 Q2 | -2.48 Million USD | -579.74% |
| 2006 Q1 | 518.59 Thousand USD | 213.08% |
| 2006 FY | - USD | -49.44% |
| 2006 Q3 | -815.97 Thousand USD | 67.2% |
| 2005 Q2 | -1.25 Million USD | -68.15% |
| 2005 Q3 | 1.02 Million USD | 181.57% |
| 2005 Q4 | -458.59 Thousand USD | -144.67% |
| 2005 FY | - USD | 72.2% |
| 2005 Q1 | -748.47 Thousand USD | 43.26% |
| 2004 Q3 | -469.78 Thousand USD | 71.93% |
| 2004 Q4 | -1.31 Million USD | -180.81% |
| 2004 FY | - USD | -18.0% |
| 2004 Q1 | -1.72 Million USD | -25.85% |
| 2004 Q2 | -1.67 Million USD | 2.7% |
| 2003 Q3 | -1.32 Million USD | -25.32% |
| 2003 Q1 | -804.84 Thousand USD | 16.59% |
| 2003 Q4 | -1.36 Million USD | -3.1% |
| 2003 FY | - USD | -44.96% |
| 2003 Q2 | -1.05 Million USD | -31.44% |
| 2002 Q1 | -646.59 Thousand USD | -4.27% |
| 2002 FY | - USD | -31.8% |
| 2002 Q4 | -964.93 Thousand USD | -74.14% |
| 2002 Q3 | -554.11 Thousand USD | 35.89% |
| 2002 Q2 | -882.41 Thousand USD | -39.54% |
| 2001 Q1 | 45.73 Thousand USD | 104.17% |
| 2001 FY | - USD | 61.34% |
| 2001 Q4 | -916.48 Thousand USD | 60.95% |
| 2001 Q3 | -1.51 Million USD | -525.8% |
| 2001 Q2 | -306.4 Thousand USD | -483.69% |
| 2000 Q2 | -1.01 Million USD | 23.19% |
| 2000 Q1 | -1.29 Million USD | -111.12% |
| 2000 FY | - USD | -92.99% |
| 2000 Q3 | -2.24 Million USD | -128.55% |
| 2000 Q4 | -1.59 Million USD | 31.69% |
| 1999 Q4 | -600 Thousand USD | 14.29% |
| 1999 Q1 | -873.83 Thousand USD | -12.5% |
| 1999 FY | - USD | 16.22% |
| 1999 Q3 | -700 Thousand USD | 30.0% |
| 1999 Q2 | -879.95 Thousand USD | -11.11% |
| 1998 Q4 | -800 Thousand USD | 42.86% |
| 1998 Q1 | 500 Thousand USD | 155.56% |
| 1998 Q2 | -2.2 Million USD | -540.0% |
| 1998 Q3 | -1.3 Million USD | 36.36% |
| 1998 FY | - USD | -68.18% |
| 1997 FY | - USD | -340.0% |
| 1997 Q1 | 100 Thousand USD | 0.0% |
| 1997 Q2 | 100 Thousand USD | 0.0% |
| 1997 Q3 | -100 Thousand USD | -200.0% |
| 1997 Q4 | -900 Thousand USD | -800.0% |
| 1996 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alvotech | -484.86 Million USD | 117.357% |
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 72.705% |
| Journey Medical Corporation | 1.92 Million USD | -4281.023% |
| Dynavax Technologies Corporation | 9.66 Million USD | -770.675% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 152.979% |
| PainReform Ltd. | -9.56 Million USD | 979.501% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 2300.582% |
| SCYNEXIS, Inc. | 73.47 Million USD | -14.535% |
| Silver Spike Investment Corp. | 7.34 Million USD | -1046.569% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 2300.582% |
| Bright Green Corporation | - USD | -Infinity% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 156.066% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | -7020.09% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 23.015% |
| Alpha Teknova, Inc. | -25.53 Million USD | 429.533% |
| Embecta Corp. | 245.4 Million USD | 65.705% |
| Safety Shot Inc | -12.18 Million USD | 790.67% |
| Procaps Group, S.A. | 104.02 Million USD | 19.098% |
| Cosmos Health Inc. | -17.06 Million USD | 593.263% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | 3679.715% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 48.336% |
| Theratechnologies Inc. | -10.31 Million USD | 916.068% |
| Harrow Health, Inc. | 9.72 Million USD | -765.571% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | 1959.878% |
| Biofrontera Inc. | -18.45 Million USD | 556.075% |
| DURECT Corporation | -24.68 Million USD | 440.947% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 14.352% |
| Cronos Group Inc. | -72.14 Million USD | 216.647% |
| OptiNose, Inc. | -15.55 Million USD | 641.114% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 109.1% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 333.245% |
| RedHill Biopharma Ltd. | 26.26 Million USD | -220.41% |
| Organogenesis Holdings Inc. | 36.03 Million USD | -133.575% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | 2245.636% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | 11939.271% |
| Radius Health, Inc. | 38.31 Million USD | -119.68% |
| Universe Pharmaceuticals INC | -3.21 Million USD | 2717.656% |
| ProPhase Labs, Inc. | -14.82 Million USD | 667.609% |
| Phibro Animal Health Corporation | 84.6 Million USD | 0.529% |
| Procaps Group S.A. | 104.02 Million USD | 19.098% |
| TherapeuticsMD, Inc. | -8.4 Million USD | 1101.779% |
| Viatris Inc. | 3.51 Billion USD | 97.607% |
| Rockwell Medical, Inc. | -4.69 Million USD | 1892.916% |
| Aytu BioPharma, Inc. | -1.01 Million USD | 8416.152% |
| Tilray Brands, Inc. | -72.84 Million USD | 215.535% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | -10264.465% |
| Shineco, Inc. | -26.55 Million USD | 416.938% |
| PetIQ, Inc. | 81.48 Million USD | -3.281% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | 2426.371% |
| Incannex Healthcare Limited | -18.5 Million USD | 554.818% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 79.774% |
| Alimera Sciences, Inc. | 7.27 Million USD | -1056.672% |
| Assertio Holdings, Inc. | -222.44 Million USD | 137.833% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | 2208.917% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | 2098.149% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | 600.83% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 520.151% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 156.436% |
| Hempacco Co., Inc. | -12.77 Million USD | 758.872% |
| Talphera, Inc. | -9.84 Million USD | 955.105% |
| Alvotech | -484.86 Million USD | 117.357% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | -8.59% |
| Lantheus Holdings, Inc. | 491 Million USD | 82.86% |
| Currenc Group, Inc. | -1.9 Million USD | 4528.107% |
| Kamada Ltd. | 21.53 Million USD | -290.821% |
| Indivior PLC | 66 Million USD | -27.514% |
| Evoke Pharma, Inc. | -7.29 Million USD | 1254.087% |
| Flora Growth Corp. | -45.87 Million USD | 283.474% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 520.151% |
| Evolus, Inc. | -41.81 Million USD | 301.29% |
| HUTCHMED (China) Limited | 25.52 Million USD | -229.675% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 65.146% |
| Akanda Corp. | -27.73 Million USD | 403.434% |